Chronic manganese (Mn) exposure induces neurotoxicity, which is characterized by Parkinsonian symptoms resulting from impairment in the extrapyramidal motor system of the basal ganglia. Mitochondrial dysfunction and oxidative stress are considered key pathophysiological features of Mn neurotoxicity. Recent evidence suggests astrocytes as a major target of Mn neurotoxicity since Mn accumulates predominantly in astrocytes. However, the primary mechanisms underlying Mn-induced astroglial dysfunction and its role in metal neurotoxicity are not completely understood. In this study, we examined the interrelationship between mitochondrial dysfunction and astrocytic inflammation in Mn neurotoxicity. We first evaluated whether Mn exposure alters mitochondrial bioenergetics in cultured astrocytes. Metabolic activity assessed by MTS assay revealed an IC 50 of 92.68 mM Mn at 24 h in primary mouse astrocytes (PMAs) and 50.46 mM in the human astrocytic U373 cell line. Mn treatment reduced mitochondrial mass, indicative of impaired mitochondrial function and biogenesis, which was substantiated by the significant reduction in mRNA of mitofusin-2, a protein that serves as a ubiquitination target for mitophagy. Furthermore, Mn increased mitochondrial circularity indicating augmented mitochondrial fission. Seahorse analysis of bioenergetics status in Mn-treated astrocytes revealed that Mn significantly impaired the basal mitochondrial oxygen consumption rate as well as the ATP-linked respiration rate. The effect of Mn on mitochondrial energy deficits was further supported by a reduction in ATP production. Mn-exposed primary astrocytes also exhibited a severely quiescent energy phenotype, which was substantiated by the inability of oligomycin to increase the extracellular acidification rate. Since astrocytes regulate immune functions in the CNS, we also evaluated whether Mn modulates astrocytic inflammation. Mn exposure in astrocytes not only stimulated the release of proinflammatory cytokines, but also exacerbated the inflammatory response induced by aggregated a-synuclein. The novel mitochondria-targeted antioxidant, mito-apocynin, significantly attenuated Mninduced inflammatory gene expression, further supporting the role of mitochondria dysfunction and oxidative stress in mediating astrogliosis. Lastly, intranasal delivery of Mn in vivo elevated GFAP and depressed TH levels in the olfactory bulbs, clearly supporting the involvement of astrocytes in Mninduced dopaminergic neurotoxicity. Collectively, our study demonstrates that Mn drives proinflammatory events in astrocytes by impairing mitochondrial bioenergetics.
Introduction
Central nervous system (CNS) aberrations resulting from prolonged exposure to transition metals, such as iron (Febbraro et al., 2012; Galvin et al., 2000; Gregory et al., 2009) , lead (Bihaqi and Zawia, 2013) , and manganese (Gorojod et al., 2015; Hesketh et al., 2008) , lend support to the potential involvement of environmental metal exposure in the etiology of chronic neurodegeneration (Rokad et al., 2016) . Manganese (Mn) toxicity resulting from overexposure to airborne sources was first noted in miners (Peres et al., 2016; Rodier, 1955) , and subsequently in industrial workers like welders (Horning et al., 2015; Kwakye et al., 2015) . Although Mn has a multitude of physiological functions (e.g., enzyme cofactor for superoxide dismutase and arginase, immunity, bone development, and reproduction) (Karki et al., 2015) , the accruing toxic levels has been shown to predominately localize to the globus pallidus, as well as other brain areas of the extrapyramidal motor system, thereby leading to a condition termed manganism, which is phenotypically similar to PD (Kwakye et al., 2015; Milatovic et al., 2007) . In addition, diets including grains, legumes, baby formulations and nuts represent the main source of Mn, of which <5% is intestinally absorbed (Karki et al., 2013; Kwakye et al., 2015) . Approximately, 30-40% of inhaled Mn is absorbed into the bloodstream, where it is transported primarily bound to albumin and b-globulin in oxidation state 2 (Mn 2+ ) (Karki et al., 2013) ; however, the absorbed proportion could be smaller ($10.6%) because of oxidative state-dependent differences in solubility (Ellingsen et al., 2003) . Availability of the Mn 2+ oxidation state in the central nervous system (CNS) is facilitated by transporters such as divalent metal ion transporter 1 (DMT1) and SLC13A10, while Mn 3+ is facilitated by transferrin (Chen et al., 2015; Karki et al., 2015; Leyva-Illades et al., 2014; SidorykWegrzynowicz and Aschner, 2013) . As a ubiquitous constituent and physiological glue of the CNS, astrocytes are indispensable for cellular homeostatic maintenance (Volterra and Meldolesi, 2005) . Astrocytes regulate extracellular glutamate levels among neurons in tripartite synapses (Karki et al., 2013; Popoli et al., 2011) . Excessive Mn can disrupt this regulation by inducing tumor necrosis factor-a (TNFa), a secreted proinflammatory cytokine. Previous studies demonstrated that Mn impairs calcium (Ca 2+ ) homeostasis in astrocytes and activates key proinflammatory events such as NFkB, NOS2 and cytokine production (Karki et al., 2014 (Karki et al., , 2015 . This inflammatory response increases expression of yin yang-1, a transcription repressor that inhibits production of excitatory amino acid transporter-2, which is necessary for glutamate reuptake (Karki et al., 2014 (Karki et al., , 2015 . Recent studies also demonstrate that Mn interferes with neurodegenerative disease-specific proteins including prions, alphasynuclein, and huntingtin (Bichell et al., 2017; Choi et al., 2007 Choi et al., , 2010 Harischandra et al., 2015) , as well as protein misfolding, which may further contribute to neuroinflammation. Thus, Mn exposure can activate the inflammatory response in astrocytes, which can further contribute to Mn neurotoxicity.
Along with pericytes, the end-feet of astrocytes envelope blood vessels to regulate blood-brain barrier trafficking (Pekny and Pekna, 2014) . Interestingly, astrocytes have been demonstrated to have an increased affinity for Mn, with concentrations up to 50-fold greater than in neurons (Aschner et al., 1992; Gonzalez et al., 2008) . Once internalized, Mn is sequestered by mitochondria via the Ca 2+ uniporter (Gunter et al., 2006) . Kinetical analyses revealed the influx of Mn through this mitochondrial uniporter is slower than Ca 2+ per se, but Mn efflux is far slower (Gavin et al., 1990; Martinez-Finley et al., 2013) . Even though the atomic charge properties and size of Mn are quite analogous to Ca 2+ , the two Ca 2+ efflux mechanisms are poor exporters of Mn, thus explaining the mitochondrial sequestration of Mn (Gunter et al., 1975; Gunter and Sheu, 2009; Martinez-Finley et al., 2013) . On the other hand, although sodium (Na + )-independent Ca 2+ efflux does transport Mn, Na + -dependent Ca 2+ efflux, the predominant mechanism in CNS mitochondria, has not been reported to export Mn (Gavin et al., 1990; Gunter and Sheu, 2009; Martinez-Finley et al., 2013 ). This extremely sluggish efflux of Mn potentially explains the prolonged CNS clearance and the buildup of toxicity (MartinezFinley et al., 2013) . Mn can also competitively inhibit both efflux pathways, thereby raising the mitochondrial Ca 2+ concentration, which can impair aerobic respiration and elicit reactive oxygen species (ROS) generation (Gavin et al., 1990; Martinez-Finley et al., 2013; Streifel et al., 2013; Tjalkens et al., 2006) . Despite the known effects of Mn on astrocytes, the extent of Mn-induced structural and functional impairment of mitochondrial dynamics and its consequent neuroinflammatory processes as it relates to Mn neurotoxicity have not been systematically examined. In the present study, we characterized the impact of Mn on mitochondrial bioenergetic flux in astrocytes (using the Seahorse bioenergetic analyzer) and its functional consequence on neuroinflammation. Our results demonstrate that overexposure to Mn (i) lowers basal respiration in astrocytes, (ii) induces astrocytic inflammation that is not exclusive to TNFa, and (iii) potentiates aggregated a-synuclein (aSyn agg )-induced inflammation in astrocytes. Thus, our study establishes a functional interaction between mitochondrial dysfunction and astrocytic inflammation in Mn-induced neurotoxicity. In addition, we report that the mitochondria-targeted anti-oxidant mito-apocynin attenuates Mn-induced astrocyte inflammation.
Methods

Chemicals and reagents
Dulbecco's modified eagle medium (DMEM), fetal bovine serum (FBS), L-glutamine (Q), and penicillin/streptomycin (P/S) were obtained from Invitrogen (Carlsbad, CA 
Animal study
Eight-week-old male C57BL/6Ncrl mice, obtained from Charles River, were housed under standard conditions of constant temperature (22 AE 1 C), humidity (relative, 30%), and a 12 h light/dark cycle. After acclimating for 3 days, mice were exposed to 50 mL of 20 mM of Mn (200 mg). This dose is consistent with previously published literature (Moberly et al., 2012) . According to reports from Centers for Disease Control and Prevention, the ambient level of Mn near industrial sites is 0.2-0.33 mg/m 3 . Hence the dose used is environmentally relevant (https://www.atsdr.cdc. gov/toxprofiles/tp151-c2.pdf). Use of animals and protocol procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at Iowa State University (Ames, IA, USA). Intranasal delivery was preferred because it takes advantage of an incomplete blood-brain barrier in the olfactory epithelium. The olfactory nerves can completely bypass the blood-brain barrier, thus chemicals can be taken up by these neurons and transported directly into the brain (Graff and Pollack, 2005) . Also, environmental exposure is usually occupation-related inhalation. Following the treatments, we carried out behavioral, biochemical and neurochemical studies.
Cell culture and treatments
One-day-old C57BL/6Ncrl pups were sacrificed, their brains dissected out, and a single cell suspension was prepared. After growing in culture for 16 days, astrocytes were isolated after microglia were removed using our CD11b magnetic-bead separation technique (Gordon et al., 2011; Sarkar et al., 2017) . The human astrocytic U373 cell line was obtained from ATCC and grown per ATCC protocol. Primary mouse astrocytes (PMAs) were cultured in DMEM, 10% FBS, 1% Q, and 1% P/S. Treatments for PMAs were performed in 2% FBS-containing DMEM, with 1% Q and P/S. U373s were cultured in MEM, 10% FBS, 1% Q, and 1% P/S. Treatments for U373s were performed in 2% FBS-containing MEM, with 1% Q and P/S. All treatments were for 24 h using Mn at 100 mM, aSyn agg at 1 mM, and mito-apocynin at 10 mM.
2.4. Recombinant human a-synuclein purification and aggregation BL21(DE3) strain E. coli cells were transformed using a plasmid encoding for wild-type human a-synuclein and grown on agar plate with Ampicillin (Amp) resistance. Pre-culture was prepared by inoculating a single colony from the agar plate into a tube containing 10 mL of LB broth with Amp and incubated overnight at 37 C. The following day, the pre-culture was inoculated into 1 L of LB medium containing Amp, and OD 600 was taken every hour till the culture reached an OD of 0.5. Recombinant a-synuclein expression was induced by adding 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) (Invitrogen), and the cells were further incubated at 37 C for 8 h before harvesting. Cells were lysed and recombinant a-synuclein was purified as previously described (Giasson et al., 1999; Narhi et al., 1999) . Finally, protein was lyophilized and stored at À80
C. For a-synuclein aggregation, a 70-mM recombinant protein solution was prepared by dissolving 1 mg in 1 mL of ultrapure water and shaken at a speed of 1000 rpm at 37 C for 7 days (Luk et al., 2012b) .
qRT-PCR
RNA extraction and qRT-PCR were performed as described previously (Gordon et al., 2016a; Seo et al., 2014) . Total RNA was extracted using TRIzol reagent as per the manufacturers' protocol and concentration was measured using NanoDrop. First strand cDNA synthesis was performed using an Affinity Script qPCR cDNA synthesis system (Agilent Technologies). Real-time PCR was performed with the RT 2 SYBR Green master mix (Thermo-Fisher #K0172). The following genes from QuantiTect Primer Assay (Qiagen) were used for qRT-PCR: pro-IL-1b, pro-IL-18, CSF-2, IL12b, and IL-6. The house keeping gene 18S rRNA (Qiagen #PPM57735E) was used as the reference for all qRT-PCR experiments. Dissociation curves were run to ensure a single amplicon peak was obtained. The results are reported as fold change in gene expression, which was determined via the DDCt method using the threshold cycle (Ct) value for the housekeeping gene and for the respective gene of interest in each sample (Gordon et al., 2016a; Lawana et al., 2017 ).
Western blotting
Western blot analysis was performed according to previous published protocols (Harischandra et al., 2018; Kanthasamy et al., 2012) . Briefly, tissue/cell samples were homogenized using a tissue homogenizer in RIPA buffer. Following protein isolation, the Bradford assay was performed for protein estimation. Next, 25-40 mg of protein was loaded in each well of 10-15% SDS-acrylamide gels and ran for 2 h at 110 V. After running, proteins were transferred to a nitrocellulose membrane at 27 V for 18 h at 4 C. After transfer, the membranes were blocked using LI-COR blocking buffer for 1 h at RT. Following blocking, the membranes were incubated in primary antibodies for 3-18 h, then washed with PBSTween (0.01%), incubated in infrared LI-COR secondary antibodies for 1 h, then washed again with PBS-Tween, and scanned using LI-COR scanner. The following antibodies were used: GFAP (1:1000), TH (1:1000), and iNOS (1:500). Secondary antibodies were used according to manufacturer's instructions.
Luminex multiplex cytokine analysis
Cytokine levels were assessed via Luminex cytokine assay according to our previous publications (Gordon et al., 2016b; Panicker et al., 2015) . Briefly, PMAs were treated in 96-well plates (20,000 cells/well) with 100 mL of treatment medium. Posttreatment, 40 mL of the treatment medium was collected and added to 40 mL of primary antibody conjugated to magnetic microspheres and incubated overnight at 4 C in a clear bottom, black 96-well plate. For serum cytokine levels, serum was diluted 5 times with block/store buffer containing BSA (Sigma-Aldrich), and 40 mL of diluted serum was used as the sample. After incubation, each well was triple-washed using a magnetic washer and then incubated for 1 h with secondary antibodies followed by three more washes. Lastly, samples were incubated for 30 min with streptavidin/phycoerythrin followed by another two washes. A Bio-Plex reader was used to read the 96-well plates.
MTS assays
MTS assay was performed according to our previous publications (Brenza et al., 2016; Charli et al., 2016) . Briefly, 20,000 cells/ well were plated in a 96-well tissue culture plate and exposed to 100 mL of treatment medium after attachment. Post-treatment, 10 mL of MTS dye was added to each well and incubated for 45 min at 37 C. After incubation, absorbance readings were taken using a plate reader at 490 nm, and a 640 nm readout was used for background subtraction.
Seahorse Mito-Stress analysis
A Seahorse XFe24 Analyzer was used to measure mitochondrial extracellular acidification rates (ECAR) and oxygen consumption rates (OCR) using the Mito-Stress test following a previously published protocol (Charli et al., 2016) . PMAs were plated at 20,000 cells/well of a Seahorse plate. The calibration plate was hydrated overnight in a non-CO 2 incubator. For the Mito-Stress test, 0.75 mM oligomycin, 1 mM FCCP, and 0.5 mM rotenone/ antimycin were used. The wave report generator (Agilent) and cell-phenotype report generator were used for analysis.
MitoTracker Green FM and MitoTracker Red CMXRos
MitoTracker Green FM and MitoTracker Red CMXRos were obtained from Molecular Probes and used according to our previous publications (Charli et al., 2016; Gordon et al., 2016a) . After treatment, cells were washed and incubated in MitoTracker green FM according to the concentration suggested by the manufacturer for 10-20 min in HBSS, followed by washing with HBSS. Hoechst nuclear stain was used to normalize the results. Excitation and emission readings for MitoTracker Green FM and Hoechst were taken using a plate reader at 490 and 516 nm, and 350 and 461 nm, respectfully. For the MitoTracker Red CMXRos assay, post-treatment cells were washed in fresh media and incubated in MitoTracker red dye (200 nM) for 15 min. Following incubation, cells were washed twice, fixed in 4% paraformaldehyde, mounted on slides, dried overnight, and imaged using a Nikon Eclipse C1 microscope equipped with a SPOT RT3 digital camera (Diagnostic Instruments, Sterling Heights, MI).
ATP assay
ATP assay was performed following Charli et al. (2016) with minor modifications. Briefly, 20,000 cells/well were plated in an opaque 96-well plate and exposed to 100 mL of treatment medium after attachment. After treatment, 100 mL of CellTiter-Glo Luminescent reagent from Promega was added to each well containing 100 mL of media. The samples were placed on an orbital shaker for 3 min after which they were incubated for 10 min at RT. Readings were taken using a luminometer (BioTek). Background luminescence was determined using the corresponding cell-free treatment media and the average was subtracted from the sample values.
HPLC analysis
HPLC analysis of dopamine was performed according to our previous publication (Gordon et al., 2016a) . In brief, olfactory bulb tissues were extracted using an antioxidant extraction solution (0.1 M perchloric acid containing 0.05% Na 2 EDTA and 0.1% Na 2 S 2 O 5 ) and isoproterenol (internal standard). A reversed-phase C-18 column was used to isocratically separate dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) at a flow rate of 0.6 mL/min using a Dionex Ultimate 3000 HPLC system (pump ISO-3100SD, Thermo Scientific, Bannockburn, IL) equipped with a refrigerated automatic sampler (model WPS-3000TSL). The electrochemical detection system included a CoulArray model 5600A coupled with an analytical cell (microdialysis cell 5014B) and a guard cell (model 5020) with potentials set at 350, 0, À150, and 220 mV. Data acquisition and analysis were performed using Chromeleon 7 and ESA CoulArray 3.10 HPLC Software.
Behavior analysis
The automated VersaMax Monitor (model RXYZCM-16, AccuScan, Columbus, OH) was used to measure the spontaneous openfield locomotor activity of mice in an activity chamber made of clear Plexiglas and covered with a ventilated Plexiglas lid, as described previously (Ghosh et al., 2013; Ngwa et al., 2014) . Horizontal and vertical activity data were collected and analyzed by a VersaMax Analyzer (model CDA-8, AccuScan). Locomotor activities were monitored during a 10-min test session following a 2-min acclimation period.
Data analysis
GraphPad 5.0 was used for statistical analysis with p 0.05 considered statistically significant. One-way ANOVA was used for comparison among multiple groups. In most cases, Tukey post analysis was applied. For comparing 2 groups, Student's t-test was used.
Results
Mn induced a dose-dependent decrease in mitochondrial metabolic activity in astrocytes
Mn has been shown to accumulate in mitochondria, block the electron transport chain (ETC), and alter mitochondrial permeability in astrocytes (Hazell, 2002; Rao and Norenberg, 2004) . In this experiment, we examined the effect of Mn on metabolic activity in PMA and U373 cells. Both sets of astrocytes were exposed to increasing concentrations of Mn (0.001-1 mM) for 24 h.
We observed a dose-dependent decrease in metabolic activity as determined by MTS assay. The IC 50 for inhibiting metabolic activity was determined to be 92.7 mM for PMAs (Fig. 1A) and 50.5 mM for U373s (Fig. 1B) . Thus, we used 100 mM Mn for all subsequent studies. To further validate the effect of Mn on astrocytic mitochondria, both PMAs and U373s were treated with 100 mM Mn for 24 h, and then subjected to MitoTracker green, a fluorescent dye that binds to intact mitochondria in live cells irrespective of mitochondrial potential and its intensity indicates mitochondrial health. In this assay, we observed a statistically significant loss of mitochondrial mass, suggesting a loss of mitochondrial function in PMAs ( Fig. 2A) and U373s (Fig. 2B) compared to untreated controls. Additionally, we used MitoTracker red dye to verify mitochondrial morphology in Mn treated PMAs (Fig. 2C) . Mn exposure was found to increase mitochondrial circularity, indicating augmentation of mitochondrial fission (Scott and Youle, 2010) , and it positively correlated with diminished ATP production in PMAs as determined by CellTiter-Glo Luminescent assay (Fig. 2D) . Furthermore, qRT-PCR analysis revealed that transcript levels of Mfn2, a gene involved in mitochondrial fusion and linked to PD pathology (Tang et al., 2015) , was down-regulated in response to Mn treatment (Fig. 2E) . Immunoblot analysis further showed that Mn exposure downregulated Mfn2 protein levels (Fig. 2F) . Together, these data suggest that Mn treatment reduces metabolic activity, mitochondrial mass, and dysregulates mitochondrial fission/fusion processes in both mouse and human astrocytes.
Altered mitochondrial dynamics and bioenergetics in Mn-treated astrocytes
Mn is known to alter brain mitochondrial influx/efflux kinetics, which affects energy metabolism (Gavin et al., 1990) . Thus, we examined the effects Mn treatment exerts on mitochondrial bioenergetics using the Seahorse XFe24 analyzer as described in our recent publication (Charli et al., 2016) . PMAs were treated with 100 mM Mn for 24 h, after which the Mito Stress assay was performed (Figs. 3 and 4) . The Seahorse directly measures oxygen consumption rate (OCR) (Fig. 3A) , while also monitoring the extracellular acidification rate (ECAR), an indicator of glycolysis (Fig. 4A) . Mn exposure led to a statistically significant decrease in basal mitochondrial respiration and oxygen consumption (Fig. 3A and B) when compared to untreated PMAs. Similarly, Mn exposure also reduced mitochondrial ATP production ( Fig. 3A and C) as well as the non-mitochondrial respiration rate ( Fig. 4A and B) . Thus, Mn not only diminishes astrocytic mitochondrial function, but also markedly reduces glycolytic function. Additionally, cell phenotype analysis revealed that Mn exposure shifts the astrocytes' bioenergetic phenotype from aerobic to a quiescent state (Fig. 4C) . These data collectively suggest that Mn exposure not only lowers the basal respiration rate and ATP production, but also alters the cellular phenotype by lowering glycolytic flux.
Upregulation of inflammatory genes in Mn-treated astrocytes
Although the role of mitochondrial bioenergetics has been well established in PD models, most of that research focused on neurons. More recent studies have suggested a potential link between neuroinflammation and mitochondrial defects in neuroimmune cells that may contribute to the amplification of inflammatory and neurodegenerative processes (Alfonso-Loeches et al., 2014) . To test for a potential link between mitochondrial dysfunction and inflammation in astrocytes, we treated PMAs with 100 mM Mn for 24 h. The cells were then subjected to qRT-PCR analyses and the treatment media were analyzed for the release of pro-inflammatory cytokines. As revealed by qRT-PCR, Mn treatment increased mRNA levels of the pro-inflammatory factors IL12b (Fig. 5A ), IL-6 (Fig. 5B) , TNFa (Fig. 5C ), NOS2 (Fig. 5D ), pro-IL1b ( Fig. 5E ) and CSF-2 (Fig. 5F ). Luminex cytokine assay revealed that Mn induced the release of the pro-inflammatory cytokines IL-6 (Fig. 5G) , IL-12 (Fig. 5H) , and TNFa (Fig. 5I) in the extracellular milieu. These data suggest that Mn can activate astrocytes, leading to the induction and maturation of pro-inflammatory factors. 
Mn potentiates aSyn agg -induced inflammation in astrocytes
Misfolded aSyn (PARK1,4) has been linked to PD pathogenesis and is one of the major components of Lewy bodies (Kim et al., 2013) . In terms of gene-environment interaction between aSyn and Mn, our study showed that prolonged exposure to Mn induces aSyn aggregation . Furthermore, we and others have shown that aSyn agg induces inflammation in microglia and astrocytes (Codolo et al., 2013; Gordon et al., 2016b; Kim et al., 2013; Su et al., 2008) . Hence, we hypothesized that exposure to an environmental toxicant like Mn in tandem with aSyn agg will either have an additive or synergistic effect on inflammation. PMAs were treated with either 100 mM Mn plus 1 mM aSyn agg , 100 mM Mn alone or 1 mM aSyn agg for 24 h, and then the cells were harvested and treatment media were subjected to qRT-PCR and Luminex assays. As revealed by qRT-PCR analysis, Mn synergistically increased the aSyn agg -induced expression of pro-IL-1b (Fig. 6A) and the release of IL-1b (Fig. 6B) . Mn had an additive effect on the aSyn agg -induced pro-inflammatory factor IL-6 (Fig. 6C) and it potentiated the aSyn agg -induced increase in CSF-2 (Fig. 6E) . Furthermore, Mn potentiated the aSyn agg -induced release of the pro-inflammatory cytokines IL-12 (Fig. 6D) and TNFa (Fig. 6F) . Collectively, these data indicate that Mn exposure exacerbates inflammation elicited by aSyn agg in astrocytes.
3.5. Mito-apocynin, a novel mitochondrially targeted derivative of apocynin, attenuated Mn-induced inflammatory genes in human astrocytic culture
Our group has recently shown that mito-apocynin, a novel mitochondrially targeted derivative of apocynin, can reduce inflammation and neurodegeneration in an MPTP mouse model of PD by reducing mitochondria-mediated oxidative stress (Ghosh et al., 2016a) . If Mn-induced mitochondrial ROS contributes to astrocytic neuroinflammatory processes, then the anti-oxidant mito-apocynin should dampen Mn-induced inflammation in human astrocytic culture. U373s were co-treated with 100 mM Mn and 10 mM mito-apocynin for 24 h. Following treatment, cells were collected for mRNA analysis. As revealed by qRT-PCR, mitoapocynin significantly reduced the expression level of the proinflammatory factors pro-IL-1b (Fig. 7B ) and pro-IL-18 (Fig. 7C) induced by Mn alone. Mito-apocynin further reduced the expression of CSF-2 (Fig. 7A) . Lastly, the MitoTracker green assay revealed that mito-apocynin prevented the Mn-induced reduction of astrocytic mitochondrial mass (Fig. 7D) . These data collectively suggest that the mitochondrially targeted anti-oxidant mitoapocynin protects against Mn-induced inflammation in astrocytes by possibly dampening mitochondrial oxidative stress.
Intranasal delivery of Mn induces inflammation and TH loss in the olfactory bulbs of mice
To validate our findings from primary astrocyte cultures in animal models, we subjected C57BL/6 mice to intranasal doses of 200 mg Mn in 50 mL three times a week for 4 weeks. At the end of the treatment period, behavioral tests were performed and then OB tissues were collected for neurochemical and biochemical analyses. Mn reduced motor activity, as indicated by the significant reduction in total distance traveled (Fig. 8A) , horizontal activity (Fig. 8B) , and total movement time (Fig. 8C) . Furthermore, neurochemical analysis of the olfactory bulb revealed that intranasal delivery of Mn significantly decreased dopamine levels (Fig. 8D) , which coincided with a downregulation of TH expression (Fig. 8E) . Immunoblot analysis of OB tissues showed that Mn induced the expression of GFAP, an activation marker of astrocytes (Fig. 8F) . Additionally, iNOS expression (Fig. 8G) and serum IL-12 (Fig. 8H) were elevated, indicating that Mn elicited a proinflammatory response. Although Mn has been shown to accumulate in the striatal region, we did not observe any changes in striatal pro-inflammatory factors or TH levels (data not shown) even after 30 days. Together these data corroborate our in vitro findings, whereby Mn-induced astroglial activation is accompanied by an enhanced pro-inflammatory response.
Discussion
Neuroinflammation plays a key role in neurodegenerative disorders, including Parkinsonian syndrome (Glass et al., 2010; Golde, 2002; Herrero et al., 2015; Tansey and Goldberg, 2010; Whitton, 2007) . Even though the etiology of these diseases is not well established, the consensus is that environment plays an important role in these neurodegenerative disorders. Astrocytes, the most abundant glial cells of the brain, are a recognized source of sustained inflammation upon activation (Phillips et al., 2014) . Besides showing how the environmental neurotoxin Mn affects astrocytes, we also demonstrate its role in triggering a synergistic interaction between mitochondrial dysfunction and inflammation. Here, we show that Mn inhibits astrocytic metabolic activity and further contributes to mitochondrial dysfunction at a lower micromolar concentration than reported elsewhere for a 24-h IC 50 (Gonzalez et al., 2008; Park and Park, 2010; Yin et al., 2008) . For the first time, we demonstrate via the Seahorse bioanalyzer that Mn exposure can change the metabolic phenotype of astrocytes. We also show that Mn exposure increased the release of pro-inflammatory factors from astrocytes and potentiated the release of IL-1b initially induced by aSyn agg . Finally, we demonstrate in vivo that intranasal Mn exposure increased astrocytic activation, motor deficits and the loss of TH.
Although several studies have suggested that Mn induces mitochondrial dysfunction and impairs glutamate uptake in astrocytes (Milatovic et al., 2007; Rao and Norenberg, 2004) , none have linked mitochondrial dysfunction to inflammation. The accumulation of Mn in mitochondria induces mitochondrial dysfunction by increasing oxidative stress and impairing membrane potential (Hazell, 2002; Milatovic et al., 2007; Rao and Norenberg, 2004) . Our findings further support the role of Mn toxicity in astrocytic and mitochondrial dysfunction. We show Mninduced mitochondrial dysfunction is associated with decreased mitochondrial mass and reduced expression of the mitochondrial fusion protein Mfn2 (Fig. 2) . Mfn2 reduction has been linked to progressive loss of dopaminergic neurons in the nigrostriatal tract (Pham et al., 2012) . Furthermore, recent studies have shown that VPS35 (PARK17) modulates Mfn2 degradation leading to mitochondrial dysfunction in dopaminergic neurons (Tang et al., 2015) . On the other hand, Mfn2 overexpression can reduce astrogliosis in vitro . From the bioenergetic profile, we found that basal oxygen consumption and maximal respiratory capacity were significantly attenuated by Mn, indicating that Mn damages mitochondrial function, as further evidenced by a parallel reduction in ATP levels. Interestingly ECAR, which serves as an index of glycolysis, was reduced in cells exposed to Mn as compared to control cells. A previous study involving U87 astrocytoma cells reported a concentration-dependent decrease in the activity of several glycolytic enzymes such as hexokinase, lactate dehydrogenase, and pyruvate kinase (Malthankar et al., 2004) . Based on this study, the inhibition we observed may not be a direct effect of Mn, but rather a secondary impairment following the disruption of the electron transport chain and tricarboxylic acid cycle. Our studies raise the possibility that Mn can also inhibit glycolysis, thereby accounting for the pronounced depletion of ATP in Mn-treated cells (Fig. 2) , but further studies will be essential to understand the role of glycolytic flux under different Mn exposure times. Astrocytes provide neurotrophic and nutrient support to neighboring neurons by producing growth factors and helping to maintain neuronal function, tissue repair, and homeostasis. In contrast, reactive astroglia produce proinflammatory factors, which become toxic to neurons when persistently activated under chronic stress, thus leading to degeneration. The phenotypic switch observed in our study upon exposure to Mn may limit nutrient availability, thereby contributing to neuronal stress.
Although microglia are the major inflammatory cells in the brain, recent studies have identified astrocytes to also be a key player driving neuroinflammation and neurodegeneration (Colombo and Farina, 2016) . A few studies have suggested a possible link between Mn and inflammation in astrocytes (Hazell, 2002; Moreno et al., 2009; Moreno et al., 2008) , however, the signaling mechanisms associated with this inflammation remain elusive. In this study, we demonstrate that exposing astrocytes to Mn induced the expression and release of pro-inflammatory factors such as IL-1b, TNFa and IL-6 (Fig. 5) . Recently, IL-1b has been linked to inflammasome signaling, which has been implicated in various neurodegenerative disorders (Freeman and Ting, 2016) . In particular, the multi-protein NLRC4 inflammasome complex has been implicated in the inflammatory signaling process in astrocytes (Liu and Chan, 2014) . We are currently investigating the role of these inflammasomes in the Mn-induced inflammatory cascade in astrocytes.
Aggregated a-synuclein is the key constituent of Lewy bodies, and has been shown to be secreted from stressed or dying neurons.
Microglia cells can be activated by secreted aSyn agg , thereby inducing inflammation in PD (Alvarez-Erviti et al., 2011; Kim et al., 2013; Lee et al., 2010; Lotharius and Brundin, 2002; Luk et al., 2012a; Su et al., 2008) . Our group has previously demonstrated that long-term Mn exposure induces aSyn aggregation leading to neuronal death . We recently demonstrated that other divalent metals like copper interact with prion proteins to promote aggregation (Yen et al., 2016) . In this study, we demonstrate for the first time that Mn can also potentiate an aSyn agg -induced inflammatory response in astrocytes, further fueling the possibility of a gene-environment interaction driving inflammation and neurodegeneration (Fig. 6) .
The role of ROS generation in inflammation and neurodegenerative disorders has been well documented (Amor et al., 2010; Mittal et al., 2014) . Furthermore, oxidative stress has been linked to Mn-induced neurotoxicity (Chen and Liao, 2002) . In fact, in a recent report using antioxidants, resistance was conferred against neurotoxicity (Ghosh et al., 2016b) by reducing inflammation and oxidative stress in a neurotoxin model of PD. We also recently demonstrated that mito-apocynin, a mitochondrially targeted derivative of apocynin, can reduce inflammation in the MPTP mouse model of PD (Ghosh et al., 2016a) . We have since demonstrated that mito-apocynin reduces mitochondrial superoxide generation in neuronal cells as well as oxidative damage in MitoPark mice, a mitochondrially defective animal model of PD (Langley et al., 2017) . In this study, we demonstrate that mitoapocynin attenuated the Mn-induced inflammatory response in astrocytes by mitigating Mn's effect on mitochondrial mass (Fig. 7) . This further confirms that mitochondrial damage can directly augment inflammation in astroglial cells. Intranasal delivery of Mn can cause deficits in both spatial memory and motor function (Blecharz-Klin et al., 2012) . Likewise, in our study, intranasal delivery of Mn to C57BL/6 mice induced significant deficits in motor behavior. Our Mn treatment paradigm also depleted TH in the olfactory bulb (OB) region of the brain and increased expression of the astrocyte activation marker GFAP. In contrast, Dorman et al. (2004) did not observe upregulation of GFAP in the rat OB after 90 days of Mn exposure. This discrepancy may be attributed to species differences (mice vs. rats) and application of different Mn compounds (MnCl 2 vs. MnSO 4 ). Our studies also reveal that Mn increased the levels of pro-inflammatory cytokines (Fig. 8) . Mn is known to accumulate in the striatum, but with this acute treatment paradigm, we did not observe any changes in striatal dopamine or GFAP. Longer chronic studies are required to determine the relationship between dopamine and GFAP levels in the striatum of Mn-treated mice. Our study collectively demonstrates that Mn can (1) induce mitochondrial damage by altering mitochondrial dynamics and bioenergetic states in astrocytes, (2) increase production of proinflammatory factors in astrocytes, (3) potentiate aSyn agg -induced inflammation in astrocytes, further validating the gene-environment relationship, and (4) induce astrocyte activation and TH loss in the OB, leading to OB inflammation and decreased motor activity when administered intranasally in vivo. Our novel findings provide an important insight into how the environmental toxicant Mn modulates inflammation and metabolic activity in astrocytes. Future studies should explore the variable mechanistic basis of astrocyte-mediated neuroinflammation in Mn neurotoxicity.
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